ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Enochian Biosciences Inc

Enochian Biosciences Inc (ENOB)

0.72
0.00
(0.00%)
Closed March 27 04:00PM
0.72
0.00
( 0.00% )
Pre Market: 08:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.72
Bid
0.675
Ask
0.73
Volume
-
0.00 Day's Range 0.00
0.3928 52 Week Range 1.33
Market Cap
Previous Close
0.72
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
58,283,000
Dividend Yield
-
PE Ratio
-4.10
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-39.68M

About Enochian Biosciences Inc

Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies. The company develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccines and... Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies. The company develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccines and cures and Cellular immune-oncology products. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Enochian Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENOB. The last closing price for Enochian Biosciences was $0.72. Over the last year, Enochian Biosciences shares have traded in a share price range of $ 0.3928 to $ 1.33.

Enochian Biosciences currently has 58,283,000 shares outstanding. The market capitalization of Enochian Biosciences is $162.61 million. Enochian Biosciences has a price to earnings ratio (PE ratio) of -4.10.

ENOB Latest News

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 8-K - Current report

false 0001527728 0001527728 2024-03-11 2024-03-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares  ...

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 14)*   Renovaro...

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

    SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11)*   Renovaro Inc...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
52-0.23-24.21052631580.951.330.39281886230.62424792CS
156-3.03-80.83.7513.77990.39284132355.68201503CS
260-6.24-89.65517241386.9619.460.39282895275.46655106CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 20.70
(335.79%)
953.87k
BCGBinah Capital Group Inc
$ 18.90
(98.95%)
156.87k
PIKKidpik Corporation
$ 5.06
(54.74%)
1.54M
SSKNStrata Skin Sciences Inc
$ 0.66
(48.35%)
2
PEGRProject Energy Reimagined Acquisition Corporation
$ 11.58
(33.72%)
345
NCNANuCana PLC
$ 0.247
(-19.45%)
52.99k
WAVDWaveDancer Inc
$ 2.93
(-18.61%)
10
INOInovio Pharmaceuticals Inc New
$ 10.65
(-18.27%)
99
WETHWetouch Technology Inc
$ 1.85
(-18.14%)
2.04k
SOBRSOBR Safe Inc
$ 0.41
(-18.00%)
1.49k
KTRAKintara Therapeutics Inc
$ 0.1086
(21.34%)
12.91M
AKBAAkebia Therapeutics Inc
$ 2.54
(13.39%)
5.56M
GMDAGamida Cell Ltd
$ 0.05
(-15.54%)
2.58M
CISSC3is Inc
$ 0.0352
(-7.85%)
2.12M
PIKKidpik Corporation
$ 5.13
(56.88%)
1.55M

ENOB Discussion

View Posts
jedijazz jedijazz 20 hours ago
$RENB #AI Pioneer GEDiCube/ RenovaroCube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine https://renovarobio.com/news/ai-pioneer-gedicube-and-biotech-innovator-renovaro-biosciences-combine-forces-to-accelerate-personalized-medicine/
👍️ 1 💪 1 💯 1 😍 1 🚀 1
jedijazz jedijazz 6 days ago
$RENB $3.19 +8.50% closing the week bullish! #shortsqueeze
👍️ 1 💪 1 💯 1
jedijazz jedijazz 1 week ago
$RENB $3.17 open. GEDiCUBE Intl Ltd. A wholly owned subsidiary of NASDAQ: RENB announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics Renovaro Biosciences Inc. https://www.einpresswire.com/article/688313019/renovaro-biosciences-inc-collaborates-with-nvidia-partner-gedicube-for-advanced-cancer-diagnosis-nasdaq-renb @ein_news
$GRTX $JANX $ZVSA $ADN $IFBD $PUBM $SRFM $TMDX $HOLO $AKLI $BSGM
👍️ 1 💯 1 😍 1
jedijazz jedijazz 1 week ago
$RENB New HOD $3.05 +1.67% $RENB Great article out summarizing Renovaro Biosciences - Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
https://ir.renovarogroup.com/news/news-details/2024/Cutting-Edge-AI-Company-GEDiCube-and-Cyclomics-sign-binding-LOI-to-join-forces-and-position-themselves-at-the-forefront-of-the-global-liquid-biopsy-marketplace/default.aspx
👍️ 1 💪 1 💯 1 😍 1
jedijazz jedijazz 1 week ago
$RENB $3.04 HOD $3.13 Renovaro Inc. (NASDAQ:RENB) shares shot up 4% during trading. The company traded as high as $3.13 and last traded at $3.04.
👍️ 1 💪 1 💯 1 😍 1
glenn1919 glenn1919 3 weeks ago
RENB.........................................https://stockcharts.com/h-sc/ui?s=RENB&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
jedijazz jedijazz 3 weeks ago
$RENB opens higher $2.58 +11.69% #bullish
👍️ 1 💪 1 💯 1 😍 1
jedijazz jedijazz 4 weeks ago
$RENB $2.50 +.29 +13.12% Weekly Chart is Bullish.
👍️ 1 💪 1 💯 1 😍 1 🚀 1
budfoxfun budfoxfun 4 weeks ago
$RENB heading for $3.00's soon!
👍️ 2 💪 1 💯 1
jedijazz jedijazz 4 weeks ago
$RENB $2.38 +8.18% In early trading #TuesdayVibes
👍️ 2 💪 1
budfoxfun budfoxfun 1 month ago
$RENB green in power hour!
👍️ 1
jedijazz jedijazz 1 month ago
$RENB $2.19 +6.07% GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace https://finance.yahoo.com/news/cutting-edge-ai-company-gedicube-142500523.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
👍️ 2 💪 1 💯 1
budfoxfun budfoxfun 1 month ago
Cyclomics has developed a groundbreaking diagnostic method for monitoring early cancer recurrence named โ€œCyclomicsSeqโ€- a novel ctDNA (circulating tumor DNA is tumor-derived fragmented DNA in the bloodstream that is not associated with cells) detection assay based on Oxford Nanopore sequencing which delivers fast, low-cost, and point-of-care sequencing. In contrast to available ctDNA-based methods, โ€œCyclomicsSeqโ€ ensures that even a single ctDNA molecule in the blood can be detected at very high accuracy. This solution consists of a new diagnostic kit (CyclomicsSeq), which has been licensed to Oxford Nanopore (LON: ONT), an RNA/DNA next-generation sequencing platform company.

$RENB
👍️ 2
jedijazz jedijazz 1 month ago
$RENB Great volume and price action this week!
👍️ 2 💪 2 😍 2
budfoxfun budfoxfun 1 month ago
$RENB 2.15 ready to go!
👍️ 1
budfoxfun budfoxfun 1 month ago
A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing.

$RENB
👍️ 1
JACKPOT JACKPOT 1 month ago
Piker
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB Breakthrough Testing with Nvidia AI Chips, Cyclomics and GEDICube; Early Cancer Detection: Renovaro: NASDAQ: RENB



https://www.einpresswire.com/article/690522470/breakthrough-testing-with-nvidia-ai-chips-cyclomics-and-gedicube-early-cancer-detection-renovaro-nasdaq-renb via @ein_news
👍️ 2 💪 1 💯 1 😍 1
budfoxfun budfoxfun 1 month ago
$RENB 2.17 ready to fall!
👍️ 1
jedijazz jedijazz 1 month ago
$RENB - Renovaro Biosciences Collaborates with NVIDIA Partner GEDiCUBE for Advanced Cancer Diagnosis: (Nasdaq: RENB) https://www.einpresswire.com/article/688313019/renovaro-biosciences-inc-collaborates-with-nvidia-partner-gedicube-for-advanced-cancer-diagnosis-nasdaq-renb via @ein_news $NVDA
👍️ 1 💯 1 😍 1
jedijazz jedijazz 1 month ago
$RENB $2.10 +3.96% Renovaro Inc Unleashes Impressive Growth in Q2 2024, Boosting Shareholders' Fortunes $RENB #Stockmarket #Nasdaq Renovaro Inc: A Leader in Major Pharmaceutical Preparations Renovaro Inc has been a key player in the major pharmaceutical preparations industry. https://t.co/fzyUKz3xmN
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB (NASDAQ: RENB), GEDICube announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics, a Dutch Company.
GEDiCube is committed to the early detection of cancer
Cyclomicsโ€™ Omni-Omic 4th generation technology, we believe, will disrupt the cancer diagnostics market and clinical practice by enabling fast and reliable results and delivering superior performance to standard radiological and physical examination alone.

https://finance.yahoo.com/news/cutting-edge-ai-company-gedicube-142500523.html
๐Ÿ‘๏ธ0
lucky, mydog lucky, mydog 1 month ago
that pumper clown stuff doesn't appear to be working.
👍️ 1
budfoxfun budfoxfun 1 month ago
$RENB GEDiCubeโ€™s award-winning AI is developing high-performance biomarker panels for 13 different cancers.https://finance.yahoo.com/news/cutting-edge-ai-company-gedicube-142500523.html
👍️ 1 💯 1
lucky, mydog lucky, mydog 1 month ago
wow! did anyone who cares not know that?
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB $2.32 +2.20% up in pre-market #happyTuesday
👍️ 1 💪 1 💯 1
Stengaard_dk Stengaard_dk 1 month ago
Obviously we are still a long way from where we were, but it looks as if Hindenburg is on the defensive - volume is down (relatively) and the big sell-off from retail investors and margin-accounts did not materialize. (There have to my knowledge not been any margin-accounts with Renovaro)

So where does that leave HR - to put it bluntly "they are up shit-creek without a paddle" because after have shorted more than +1 million shares at prices over 4 (and the +300K shares sold immediately after release of report) they have not been able to buy them back at expected sub 2 levels. I know danish retail investors have added close to 400,000 this week .

Hindenburg et al (they were not in this alone) - can (as they did last time) reach out to Wall Street parasites such as H.C. Wainwright and ask them to offer funding to Renovaro. Only this time I am hopefull/certain that Renovaro will find other means of raising capital - other than through the H.C.W-scumbags and the likes. (Wainwright is under investigation for facilitating naked shorting)
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB 2.392 +19.60% Strong move against shorts.
👍️ 1 🚀 1
lucky, mydog lucky, mydog 1 month ago
what findings did they dispute?
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB $2.05 +2.50% Great Article #nasdaq "Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion Piece" $RENB #shortsqueezehttps://www.benzinga.com/general/biotech/24/02/37133612/hit-with-short-seller-report-renovaro-biosciences-comments-on-hindenburgs-opinion-piece via @Benzinga
👍️ 1
budfoxfun budfoxfun 1 month ago
$RENB (Nasdaq: RENB) Renovaro Biosciences Inc. Collaborates with NVIDIA Partner GEDiCUBE for Advanced Cancer Diagnosis: https://www.einpresswire.com/article/688313019/renovaro-biosciences-inc-collaborates-with-nvidia-partner-gedicube-for-advanced-cancer-diagnosis-nasdaq-renb via @ein_news
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB - GEDiCube is focused on developing advanced diagnostic and monitoring tests that use multi-omics, integrating data from each stage of genetic expression, including genomics, epigenomics, transcriptomics, proteomics, fragmentomics, and metabolomics. As a member of the Nvidia Inception Program, the company will integrate medical imaging into its AI engine.
๐Ÿ‘๏ธ0
jedijazz jedijazz 1 month ago
$RENB - GEDiCubeโ€™s platform technology deploys next-generation AI running on NVIDIA's latest chips and stacks genetic and protein expression on top of DNA mutation for accuracy in cancer detection.
๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
And you know what they say: "Falsus in uno, falsus in omnibus".

No one will ever trust him again. And no one should.
👍️ 1
Stengaard_dk Stengaard_dk 1 month ago
you are right Serhat will always be a problem for Renovaro.

Of course he is not yet convicted of the murder for hire - but one or two of the other suspects have entered a plea deal - so things look pretty bleak for him. I have NO interest in defending him or his actions

For the record- if I remember correctly the science he falsified was on Covid. (that's bad enough) The results on HPV were actually positive but he decided to enhance/multiply the effect and lied about the number of test he ran. So in theory it may work given time and modifications but we will probably never know.

Good night..
๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
after the newly imposed rules on naked shorting in the US (which you should have had long time ago- like we have in Europe)

We do have rules about naked shorting. They're called Regulation SHO, and initially became effective in early 2005. They were then amended to make them more comprehensive in 2007.

https://www.sec.gov/rules/2004/07/short-sales#:~:text=Regulation%20SHO%20defines%20ownership%20of,the%20Commission%20to%20suspend%20temporarily

And this, updated in 2022, is more digestible:

https://www.sec.gov/investor/pubs/regsho.htm

Reg SHO worked. The SEC finds mismarked tickets now and then, and punishes the perps. But "NSS" isn't a problem successful companies complain about. Usually, the real problem is toxic funders. The guys who buy promissory notes that convert at an enormous discount to market, and then dump them on the market. The notes are also known as "death spiral convertibles".

See you tomorrow!
👍️ 1
janice shell janice shell 1 month ago
Thanks again. That makes sense. For some reason, the SEC calls the company Enochian merged with "DanDrit", as if it were a person's name.

Whatever made Serhat do what he did, he DID do it. Tons of crimes. Even more lies. I don't think he'll be doing any more science...
๐Ÿ‘๏ธ0
Stengaard_dk Stengaard_dk 1 month ago
I am not so certain - after the newly imposed rules on naked shorting in the US (which you should have had long time ago- like we have in Europe) naked short-sellers need to get creative .
I have received a "guide-book" on how it's done (I won't publish it - no need to make it even more known) but it's quite ingenious. One of the things you need is a clandestine listing -
Boerse Berlin actually writes that the (listed) company has no obligations towards them - so I doubt there is any communication

Anyway - its quite late here - if further questions I'll be happy to help tomorrow :)
๐Ÿ‘๏ธ0
Stengaard_dk Stengaard_dk 1 month ago
Dandrit was formed on the pioneering research in Dendritic Cells carried out in Copenhagen way back when. I was part of the group that were involved in a listing on the Copenhagen Exchange. However we found out that the climate for start-ups at the time was not favorable. Eventually some of the other shareholders found a way to have a "backdoor" listing through Putnam Hills - a procedure that was quite common back then... The truly interesting thing is that the research is still the basis of the product showing potential to cure Pancreatic Cancer (amongst other cancers) . The product has been modified but the basic principle is (as least as I see it) still the same.
I find it hard to accept that in spite of his many many faults and obvious crimes Serhat have contributed to the modifications that made the product potent - but I take the words of Anahid Jewett (named as one of the 2% scientist in the world by Stanford) for it
๐Ÿ‘๏ธ0
lucky, mydog lucky, mydog 1 month ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173858099
๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
Yes, it seems hardly to have traded at all in Berlin. I think bringing it up is just an excuse from the company. A distraction.
๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
Many thanks. What do you think about the DanDrit part of the company? Do you have any idea why a succession of companies with something to offer would want to be bought up by a company that showed the kind of spectacularly poor judgment shown by Enochian/Renovaro?

After all, Serhat Gumrukcu was its co-founder. He hired a hitman to murder someone he'd scammed. And the hitman did it. Gumrukcu is now in prison.

And yet this company still exists.
๐Ÿ‘๏ธ0
Stengaard_dk Stengaard_dk 1 month ago
I've had shares in the company since it was called Dandrit - I think you can also call me a pretty active investor - but even so I have never heard of a dual listing in Boerse Berlin - and I am certain that there has never been any real turnover.
๐Ÿ‘๏ธ0
Stengaard_dk Stengaard_dk 1 month ago
I think I can safely say that no-one in Denmark has ever heard of a dual listing of Renovaro - and I've been a shareholder since the early Dandrit days. (I would say I know all the largest danish shareholders - except one or two) and this has never been mentioned or even hinted at.- much less a potential investigation by the SEC. '
๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
No. Though they're suspending for cause less often nowadays. Maybe they'll get some Wells notices. Most companies do disclose them, but it isn't an absolute requirement, so...
๐Ÿ‘๏ธ0
Stengaard_dk Stengaard_dk 1 month ago
this is news to me..
๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
You're welcome. Now what about the Danish angle?
๐Ÿ‘๏ธ0
Stengaard_dk Stengaard_dk 1 month ago
thanks :)

๐Ÿ‘๏ธ0
janice shell janice shell 1 month ago
You should have 30 posts per day now. If you don't, go to this address and send a private message to an admin:

https://investorshub.advfn.com/boards/profile.aspx?user=111041

Are you from Denmark, or do you have connections there? Any thoughts about the Danish part of the company? Any ideas about the Berlin listing?
๐Ÿ‘๏ธ0
lucky, mydog lucky, mydog 1 month ago
i don't think anyone would be shocked to see an sec suspension.
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock